Jazz Pharmaceuticals plc
JAZZ
Jodie situation report
Jazz Pharmaceuticals plc's current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 12 directly disclosed connections are confirming.
- Revenue increased 15.5% versus the comparable filing period.
- R&D costs increased as clinical studies and outside services for zanidatamab rose, with Jazz expecting further R&D growth.
- Zepzelca sales growth is tied to increased volume and adoption in first-line maintenance ES-SCLC, partly offset by lower second-line use.
Invalidation: The isolated read changes if JAZZ's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind JAZZ
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AMRXAmneal Pharmaceuticals, Inc.customerAug 6, 2025 ▾
“Specifically, a wholly owned subsidiary of Hikma launched its AG version of sodium oxybate in January 2023 and Amneal launched its AG version of sodium oxybate in July 2023.”
ALKSAlkermes plcpartnerFeb 24, 2026 ▾
“In addition, Alkermes acquired Avadel in February 2026, which may strengthen both companies and 23 Table of Contents we may experience increased competition from the combined company.”
Depended on by
ALKSAlkermes plcpartnerMay 5, 2026 ▾
“Pursuant to the settlement and license agreement entered into between Jazz Pharmaceuticals entities and Avadel entities in October 2025 (the “Avadel Settlement Agreement”), from October 1, 2025, Jazz receives a royalty of 3.85% (subject to certain adjustments…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 12 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
JAZZ is currently a Leader in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.